Sirio Pharma Announces Agreement to Acquire Best Formulations

Sirio Pharma Co., Ltd. (Sirio) and Best Formulations, Inc. (Best) today announced that they have entered into an agreement for Sirio to acquire 80% equity of Best, a contract manufacturer of nutraceuticals and dietary supplements based in City of Industry, California. Best Formulations, founded in 1984, is a leading contract manufacturer of softgels in North … Read more

Categories New

Biological Probiotics Project of RMB 1 Billion Yuan (USD $150 Million) Landed in Yancheng

From the first online investment promotion, to a contract signed in the field, the Yancheng area only used 30 days to land a biological probiotic project cooperation agreement with Ningxia Jiusheng Biotechnology Company. This project plans to invest RMB 1 billion yuan (USD $150 million) to build a biological probiotic research and development center and … Read more

Categories New

Association Standard for Probiotics was Released

In order to promote the standardization and development of the probiotic market, China Nutrition and Health Food Association released the association standard T/CNHFA 006-2022 “Probiotic Food Survival Rate Grading Specification”. When probiotic food has been stored for one-third of shelf life under the condition as indicated on the label, the survival rate of probiotic live … Read more

Categories New

ChromaDex Announces Joint Venture in China

The signed agreement establishes beachhead to broadly market and distribute Tru Niagen® to Mainland China’s aging population LOS ANGELES–(BUSINESS WIRE)– ChromaDex Corp. (NASDAQ:CDXC) (“the Company”) a global bioscience company dedicated to healthy aging, today announced it has entered into an agreement (the “JV Agreement”) to establish a joint venture through its wholly owned subsidiary ChromaDex … Read more

Categories New

Import and Export Analysis of Nutritional Health Food in 2021

According to data from China Chamber of Commerce (CCCMHPIE), the import amount of nutritional health food is in a continuous growth trend. Since 2016, the import amount has grown rapidly, and the growth rate of import amount in 2021 is 237.0% compared with 2016 and nearly 12 times compared with 2008. This data demonstrates the … Read more

Categories New

Probiotics China News Bites – April 2022

Probiotics China team interviewed Sacco CSL with its CEO for Asia-Pacific, Mr. John Goebel. Link to interview is HERE. (Interview is in Chinese) Two Probiotics related products from AB-Biotics, the Lipigo and AB-21 won the 2022 Nutraingredients Awards. AB-Biotics presented its starter product Yogumel for making yogurt or kefir at the Alimentaria food show in … Read more

Categories New

NutraIngredients-Asia Awards Back for 5th Year

Entries are open for the NutraIngredients-Asia Awards 2022, held to honour the best supplements and functional foods products, ingredients, research and companies operating in Asia Pacific. The awards are open to companies across the globe, providing their products or ingredients are available in at least one APAC market. This year we have 17 categories spanning ingredients, … Read more

Categories New

Probiotics China News Bites – March 2022

Novozymes conducted a comprehensive consumer survey in March, pointed out that in the post-epidemic era, consumers are more concerned about their physical and mental health, and are more inclined to choose natural and clean products. From the perspective of the consumer market, the categories between products have become blurred, and there are often “cross-border” products … Read more

Categories New

Probiotics China News Bites – February 2022

Probiotics Online released the exclusive interview with Mr. Jordi Riera Alsina, the Chief Business Development Officer of AB-Biotics S.A: AB-Biotics Leads the Rise of Natural Probiotics. ADM released a report about future dietary supplement consumers, pointing out that 64% global consumers believe that mindful enjoyment can be part of a healthy diet, and companies are … Read more

Categories New

BY-HEALTH’s Performance in 2021

In 2021, BY-HEALTH achieved revenue of RMB 7.431 billion yuan (USD $1.17 billion), with an increase of 21.94% year-on-year, and achieved net profit of RMB 1.754 billion yuan (USD $280 million), with an increase of 15.09% year-on-year. Within the year, BY-HEALTH raised another RMB 1.9 billion yuan (USD $300 million) for capital, mainly used for … Read more

Categories New